Compare Amphastar Pharmaceuticals Inc (AMPH) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

TLH trades at $98.50, down 0.04% on the day, with technical indicators showing a bearish trend as moving averages signal strong selling pressure. The stock faces resistance at $99 and finds support at $98. Recent dividends of $0.41 and $0.36 were declared for H1-26 and H2-26 respectively, providing income to shareholders amid current market volatility.

The outlook remains cautious due to bearish technical signals and broader market uncertainty. Key risks include macroeconomic pressures from potential Fed rate hikes and geopolitical tensions affecting energy markets. Investors should monitor earnings reports for fundamental strength validation.